Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06757504RecruitingPhase 2
Testing TTYP01 tablets for autism in kids and teens
This study tests an investigational tablet (TTYP01) to see if it can help adolescents and children with autism spectrum disorder (ASD). The goal is to find out if the drug improves symptoms and is safe for this age group.
BeijingAges 6–16 - NCT07093073RecruitingPhase 1
CAR-T therapy for B-cell lymphoma
This trial tests a new CAR-T cell therapy (called ssCART-19) for people with B-cell lymphoma that has not responded to standard treatments or has come back. The therapy uses your own immune cells to target and kill cancer cells.
ShanghaiAges 2–75 - NCT07090395Recruiting
Expanding use of EVO oral appliance for severe sleep apnea
This trial tests whether an EVO oral appliance can treat severe obstructive sleep apnea in people who haven't used other treatments recently. It aims to see if the device works for a wider group of patients.
New York, New YorkAges 18–80 - NCT07090200Recruiting
Rehabilitation program for COPD with heart or blood vessel disease
This study tests a rehabilitation program for people with COPD who also have heart or blood vessel problems. It aims to help you breathe better and improve your overall health.
Wuhan, HubeiAges 18 years+ - NCT07092202RecruitingPhase 4
Firmonertinib and spinal injection for EGFR lung cancer with spread to brain lining
This trial tests combining a targeted pill (firmonertinib) with medication injected into the fluid around the spine for people with a specific type of lung cancer that has spread to the lining of the brain. It may offer a new option if you have already tried other EGFR drugs and are still having progression.
Wuhan, HubeiAges 18 years+ - NCT07093060RecruitingEarly Phase 1
Oxytocin and atosiban effects on social attention
This trial tests how two oral medications, oxytocin and atosiban, affect the way healthy men pay attention to social cues. It aims to understand how these drugs influence social brain function.
Chengdu, SichuanAges 18–35 - NCT07094763Recruiting
Tenecteplase for posterior stroke 4.5-24 hours after onset
This trial tests a clot-busting drug called tenecteplase for people who had a stroke affecting the back part of the brain (posterior circulation). It may be an option if you can get treatment between 4.5 and 24 hours after symptoms started.
HefeiAges 18–100 - NCT07092761Recruiting
Testing a new continuous glucose monitor
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
Luoyang, HenanAges 18 years+ - NCT06973408Recruiting
Diet and lifestyle study for weight management
This study tests whether a specific diet and behavior program can help people with overweight improve their health. You will be asked to follow a specific eating plan and eat certain foods provided by the researchers.
GothenburgAges 18–70 - NCT06936189Recruiting
Extended follow-up study of IVL for carotid artery disease
This trial is collecting long-term safety and effectiveness data from patients who already completed a study of a device called IVL (shockwave therapy) for calcium buildup in the carotid artery. It does not require any new treatments or tests.
BeijingAges 18–80 - NCT06897241Recruiting
How different starches affect your metabolism
This study tests how your body responds to different types of starch (quick, slow, and resistant). You will follow special diet plans and use monitoring devices to understand your personal metabolic reactions.
Gothenburg, Västra Götaland CountyAges 30–75 - NCT06936176Recruiting
Studying a new balloon procedure for calcified carotid artery disease
This trial tests a special balloon (IVL) to treat hardened plaque in the neck arteries that supply blood to the brain. It is for people who need a stent but whose previous balloon treatment did not work well.
BeijingAges 18–80 - NCT06975124RecruitingPhase 1
taVNS and fear in real-life settings
This trial tests if a gentle nerve stimulation (taVNS) can change how people feel fear in everyday situations. It may help understand new ways to manage fear and anxiety.
Chengdu, SichuanAges 18–30 - NCT07078136Recruiting
AI study for upper GI tumor diagnosis
This study uses artificial intelligence to help diagnose tumors in the upper stomach or esophagus. It looks at images from endoscopy and ultrasound to improve how doctors identify these growths.
Wuhan, HubeiAges 18 years+ - NCT07083115Enrolling by invitation
Using MRI to study atrial fibrillation
This trial uses advanced MRI scans to better understand atrial fibrillation (AFib). If you have been diagnosed with AFib and can safely undergo an MRI, you may be able to join this study at the Cleveland Clinic.
Cleveland, OhioAges 18 years+ - NCT07081711Recruiting
Testing new heart MRI technology in volunteers
This study is testing a new way to take pictures of the heart using MRI. It is looking for healthy volunteers to help make sure the technology works correctly.
Cleveland, OhioAges 18 years+ - NCT07077239Recruiting
Adaptive radiation after prostate surgery to lower side effects
This trial tests a precise, short-course radiation treatment (stereotactic body radiotherapy) after prostate removal surgery that adapts to your body each day to reduce side effects. It is for people whose prostate cancer has high-risk features or a rising PSA after surgery.
Los Angeles, CaliforniaAges 18 years+ - NCT07083336Recruiting
Diet study for type 2 diabetes with fatty liver disease
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
Yichang, HubeiAges 18 years+ - NCT06976177RecruitingPhase 2
MT1013 for secondary hyperparathyroidism in dialysis patients
This study tests a new injectable medicine called MT1013 for people with secondary hyperparathyroidism who are on regular kidney dialysis. It aims to see if MT1013 can help control high parathyroid hormone levels safely.
Hangzhou, ZhejiangAges 18 years+ - NCT06545968Recruiting
Social media to help young people with HIV stay in care
This study tests whether a social media program can help young people with HIV in Uganda stay connected to their medical care. If you are between 15 and 24 years old and are new to care or returning after a break, you may be able to join.
MbararaAges 15 years+ - NCT06978348Recruiting
AI model to predict stroke using ultrasound
This trial is building an AI tool to predict ischemic stroke risk based on carotid and vertebral artery ultrasound findings. It may help find early warning signs of a stroke before it happens.
Shanghai, Shanghai MunicipalityAges Any age - NCT06851130Recruiting
Iron supplement study for women with low iron stores
This study tests how quickly a single oral iron dose increases ferritin levels in women who have low iron stores but are not anemic. It aims to find a quick way to assess iron absorption.
Zurich, Canton of ZurichAges 18–45 - NCT06367088RecruitingPhase 2
Combination drug therapy for advanced triple-negative breast cancer
This trial tests a new drug (cadonilimab) plus chemotherapy for people with advanced triple-negative breast cancer that has come back or spread. It aims to see if the combination works better than standard treatment.
Wuhan, HubeiAges 18–70 - NCT06228794Recruiting
CPC blood test to predict multiple myeloma outcomes
This trial is studying a new blood test that measures circulating plasma cells (CPCs) to help predict how multiple myeloma may progress. It is for people newly diagnosed with multiple myeloma who have not yet started treatment.
Wuhan, HubeiAges 18–80
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.